Client News

Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT

NEW YORK, Nov. 16, 2021 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has signed a Sponsored Research Agreement with North Carolina State University (“NC State“) to support the continued research and development of HT-KIT, a novel therapeutic for the treatment mast cell cancers. The research will be led by Dr. Glenn Cruse, Assistant Professor, and […]

Troika Media Reports First Quarter Fiscal Year 2022 Results

First quarter revenue growth significantly exceeds Company forecast Revenue increased 102% quarter-over-quarter to $8.3 million Adjusted EBITDA improved 78% and net loss improved 45% quarter-over-quarter Company expects to continue revenue growth in FY 2022 Los Angeles, California, Nov. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Troika Media Group, Inc. (Nasdaq: TRKA) (“TMG” or “Company”), a brand […]

Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Longeveron to hold conference call today at 8:30 AM EST MIAMI, Nov. 12, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today provided a business update regarding the status of the Company’s various clinical research programs and reported […]

Gaucho Group Holdings, Inc. Makes Additional $3.5 Million Investment to Further Advance Las Vegas Project with LVH Holdings LLC

Company Endeavors To Expand Brand To Include Opportunities in Lodging, Hospitality, Retail, and Gaming NEW YORK, NY / ACCESSWIRE / November 11, 2021 / Gaucho Group Holdings, Inc. (NASDAQ:VINO), a company that includes a growing collection of e-commerce platforms with a concentration on fine wines, luxury real estate, and leather goods and accessories, today announced it has […]

Pressure BioSciences Awarded Second U.S. Patent for Its Revolutionary Ultra Shear Technology Platform, for Its Innovative NanoGap Valve

Dynamically-Adaptive Compact Valve is Key Component in the Company’s Highly Anticipated and Proprietary UST Platform; UST Expected to Help Deliver Strong Sales Growth and Profitability in 2022 SOUTH EASTON, MA / ACCESSWIRE / November 11, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based […]

Pasithea Therapeutics Collaborates with Renowned Musician and Producer to Create Soundtracks for Ketamine Therapy

— Music plays an important role in ketamine therapy and is known to facilitate positive outcomes — MIAMI BEACH, Fla., Nov. 11, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (Pasithea or the Company), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, […]

Gaucho Group Holdings Announces First Vineyard Estate Lot Sale in Cryptocurrency

Luxury Real Estate Development Expands Diversification Opportunity for Global Investors NEW YORK, NY / ACCESSWIRE / November 9, 2021 / Gaucho Group Holdings, Inc. (NASDAQ:VINO), a company that includes a growing collection of e-commerce platforms with a concentration on fine wines, luxury real estate, and leather goods & accessories, today announced its luxury residential vineyard real estate […]

Quipt Continues National Expansion With Closing of Strategic Acquisition in Central Illinois and Ongoing Business Momentum as Respiratory Equipment Demand Remains Elevated Into Fiscal Q1 2022

$2.5 Million in Annualized Revenues, 25% Projected Adjusted EBITDA Margin Post Integration, and Adds Over 3,700 Active Patients Quipt Has Completed 6 Acquisitions for Over $16 Million in Revenue, Adding Over 30,000 Active Patients Since July CINCINNATI, Nov. 09, 2021 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. […]

Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology

Titans and Emerging Leaders of Biopharma Struggling with Protein Misfolding and Aggregation Issues that Threaten Enormous Revenue Potentials Are Turning to PBI’s Uniquely Enabling BaroFold Solution REMINDER: PBI to Participate in the Benzinga Virtual ALL ACCESS Investor Event Today at 11:20 am ET. SOUTH EASTON, MA / ACCESSWIRE / November 4, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.